Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | Linsitinib | 10 | uM | 9 | 156.25 | 71.09 | 68.00 | 119.00 | 0.5714 | -0.0581 |
| BT-20 | 0 | uM | 9 | 156.25 | 71.09 | 161.00 | 119.00 | 1.3529 | 2.0038 | |
| BT-20 | Lapatinib | 1 | uM | 9 | 156.25 | 71.09 | 167.00 | 119.00 | 1.4034 | 2.1553 |
| BT-20 | Lapatinib | 10 | uM | 9 | 156.25 | 71.09 | 37.00 | 119.00 | 0.3109 | -0.5847 |
| BT-20 | Lapatinib | 0.0033113 | uM | 9 | 156.25 | 71.09 | 151.00 | 119.00 | 1.2689 | 1.7555 |
| BT-20 | Linsitinib | 0.1 | uM | 9 | 156.25 | 71.09 | 142.00 | 119.00 | 1.1933 | 1.5368 |
| BT-20 | Lapatinib | 0.031623 | uM | 9 | 156.25 | 71.09 | 106.00 | 119.00 | 0.8908 | 0.7117 |
| BT-20 | 17-AAG | 0.031623 | uM | 9 | 156.25 | 71.09 | 70.00 | 119.00 | 0.5882 | -0.0206 |
| BT-20 | 0 | uM | 9 | 156.25 | 71.09 | 70.00 | 119.00 | 0.5882 | -0.0206 | |
| BT-20 | 0 | uM | 9 | 312.50 | 153.73 | 265.00 | 274.75 | 0.9645 | 0.9156 | |
| BT-20 | 0 | uM | 9 | 312.50 | 153.73 | 268.00 | 274.75 | 0.9754 | 0.9415 | |
| BT-20 | Erlotinib | 0.0033113 | uM | 9 | 312.50 | 153.73 | 321.00 | 274.75 | 1.1683 | 1.4082 |
| BT-20 | 17-AAG | 0.001 | uM | 9 | 312.50 | 153.73 | 372.00 | 274.75 | 1.3540 | 1.8716 |
| BT-20 | 17-AAG | 0.000066069 | uM | 9 | 312.50 | 153.73 | 300.00 | 274.75 | 1.0919 | 1.2213 |
| BT-20 | Linsitinib | 3.1623 | uM | 9 | 312.50 | 153.73 | 255.00 | 274.75 | 0.9281 | 0.8296 |
| BT-20 | Erlotinib | 19.9526 | uM | 9 | 312.50 | 153.73 | 522.00 | 274.75 | 1.8999 | 3.3028 |
| BT-20 | Lapatinib | 0.1 | uM | 9 | 312.50 | 153.73 | 423.00 | 274.75 | 1.5396 | 2.3476 |
| BT-20 | Lapatinib | 0.0016596 | uM | 9 | 312.50 | 153.73 | 402.00 | 274.75 | 1.4631 | 2.1501 |
| BT-20 | 0 | uM | 9 | 312.50 | 153.73 | 394.00 | 274.75 | 1.4340 | 2.0755 | |
| BT-20 | 17-AAG | 0.1 | uM | 9 | 312.50 | 153.73 | 130.00 | 274.75 | 0.4732 | -0.1814 |
| BT-20 | Erlotinib | 0.1 | uM | 9 | 312.50 | 153.73 | 370.00 | 274.75 | 1.3467 | 1.8532 |
| BT-20 | Lapatinib | 0.31623 | uM | 9 | 312.50 | 153.73 | 334.00 | 274.75 | 1.2157 | 1.5250 |
| BT-20 | Linsitinib | 0.31623 | uM | 9 | 312.50 | 153.73 | 316.00 | 274.75 | 1.1501 | 1.3634 |
| BT-20 | Lapatinib | 0.01 | uM | 9 | 312.50 | 153.73 | 369.00 | 274.75 | 1.3430 | 1.8440 |
| BT-20 | Linsitinib | 0.031623 | uM | 9 | 312.50 | 153.73 | 314.00 | 274.75 | 1.1429 | 1.3456 |